A study of arteriosclerosis in healthy subjects with HBV and HCV infection

被引:26
|
作者
Moritani, M
Adachi, K
Arima, N
Takashima, T
Miyaoka, Y
Niigaki, M
Furuta, K
Sato, S
Kinoshita, Y
机构
[1] Shimane Univ, Sch Med, Dept Gastroenterol & Hepatol, Izumo, Shimane 6938501, Japan
[2] Shimane Environm & Hlth Publ Corp, Matsue, Shimane, Japan
关键词
hepatitis B virus; hepatitis C virus; cardiovascular risk factor; arteriosclerosis;
D O I
10.1007/s00535-005-1655-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. It is unclear whether infection with hepatitis B virus (HBV) or hepatitis C virus (HCV) affects arteriosclerosis. We performed a cross-sectional study to clarify the effect of HBV and HCV infection on arteriosclerosis. Methods. The study subjects were 1806 healthy individuals who visited Shimane Environment and Health Public Corporation for routine medical check-ups. Serum levels of total cholesterol, high-density lipoprotein (HDL)-cholesterol, triglycerides, and blood glucose were investigated in all subjects. The degree of arteriosclerosis was assessed using systolic blood pressure, the bilateral ankle brachial index (ABI), the heart-carotid pulse wave velocity (HCPWV), and the heart-ankle PWV (HAPWV). These cardiovascular parameters were compared between control subjects and subjects with HBV and HCV infection, using analysis of covariance to adjust for confounding factors (sex, age, body mass index, and smoking and drinking). Results. Of the 1806 subjects, 39 and .31 were diagnosed as positive for HBV and HCV infection, respectively. The remaining 1736 were considered to be the controls. Adjusted serum lipid levels in the subjects with HBV and those with HCV infection tended to be lower than those in the control subjects. Adjusted arteriosclerotic parameters in the subjects with HBV and HCV infection were similar to those in the control subjects, even after adjusting for serum lipid levels. Conclusions. Infection with HBV or HCV does not influence the severity of arteriosclerosis in healthy subjects.
引用
收藏
页码:1049 / 1053
页数:5
相关论文
共 50 条
  • [41] IMMUNOLOGICAL AND VIROLOGICAL ANALYSIS OF HBV/HCV DUAL INFECTION
    Kondo, Yasuteru
    Ueno, Yoshiyuki
    Tanaka, Yasuhito
    Ninomiya, Masashi
    Kakazu, Eiji
    Inoue, Jun
    Shimosegawa, Tooru
    HEPATOLOGY, 2011, 54 : 1098A - 1098A
  • [42] The Incidence of HBV and HCV Infection in Australian Travelers to Asia
    Johnson, Douglas F.
    Ratnam, Irani
    Matchett, Elizabeth
    Earnest-Silveria, Linda
    Christiansen, Dale
    Leder, Karin
    Grayson, Michael L.
    Torresi, Joseph
    JOURNAL OF TRAVEL MEDICINE, 2013, 20 (03) : 203 - 205
  • [43] HBV and HCV chronic infection: Autoimmune manifestations and lymphoproliferation
    Zignego, Anna Linda
    Piluso, Alessia
    Giannini, Carlo
    AUTOIMMUNITY REVIEWS, 2008, 8 (02) : 107 - 111
  • [44] HCV, HBV and Alcohol - the Dionysos Study
    Bellentani, S.
    Scaglioni, F.
    Ciccia, S.
    Bedogni, G.
    Tiribelli, C.
    DIGESTIVE DISEASES, 2010, 28 (06) : 799 - 801
  • [45] A Study on the HBV and the HCV Infections in Female Sex Workers and their Co-Infection with HIV
    Praseeda, Desai S.
    Anuradha, Dutta
    Jayanthi, Shastri S.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2013, 7 (02) : 234 - 237
  • [46] A five-year cohort study of patients with dual infection with HBV and HCV.
    Agnelli, F
    Donato, MF
    Arosio, E
    Monti, V
    Sangiovanni, A
    Lampertico, P
    Rumi, MG
    Lunghi, G
    Del Ninno, E
    Colombo, M
    HEPATOLOGY, 2003, 38 (04) : 672A - 672A
  • [47] The immunochemistry using study of stomach and duodenum membrane tissue in patients with HBV and HCV infection
    Nersessov, A. V.
    Rakhmetova, V. S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A29 - A29
  • [48] Impact of HBV infection in HCV/HBV coinfected patients treated with DAAs IN Northern Italy
    Fabris, P.
    Noventa, F.
    Pasulo, L.
    Farina, F.
    Carollo, G.
    Carlotto, A.
    Rovere, P.
    Cavinato, S.
    Romano, A.
    Vario, A.
    Fraceschet, I.
    Panese, S.
    Bertin, T.
    Zappala, F.
    Alberti, A.
    Lobello, S.
    Aghemo, A.
    Bruno, R.
    Puoti, M.
    Rizzardini, G.
    Spinelli, O.
    Pigozzi, M. G.
    Spinetti, A.
    Menzaghi, B.
    Pan, A.
    Bella, D.
    Re, T.
    Borghi, M.
    Lombardi, A.
    Vigano, M.
    Salpietro, S.
    Lleo, A.
    Fagiuoli, S.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : E19 - E20
  • [49] Seroprevalence and risk factors associated with HBV and HCV infection among subjects with type 2 diabetes from South India
    Juttada, Udyama
    Smina, T. P.
    Kumpatla, Satyavani
    Viswanathan, Vijay
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 153 : 133 - 137
  • [50] Impact if HBV infection in HCV/HBV coinfected patients treated with DAAs in north Italy
    Fabris, Paolo
    Noventa, Franco
    Fagiuoli, Stefano
    Farina, Francesca
    Carolo, Giada
    Carlotto, Antonio
    Rovere, Pierangelo
    Cavinato, Silvia
    Romano, Antonietta
    Vario, Alessandro
    Franceschet, Irene
    Panese, Sandro
    Bertin, Tosca
    Zappala, Francesco
    Alberti, Alfredo
    Lobello, Salvatore
    Aghemo, Alessio
    Bruno, Raffaele
    Puoti, Massimo
    Rizzardini, Giuliano
    Spinelli, Ombretta
    Pigozzi, Marie Graciella
    Spinetti, Angiola
    Menzaghi, Barbara
    Pan, Angelo
    Bella, Daniele
    Re, Tiziana
    Borghi, Marta
    Lombardi, Andrea
    Vigano, Mauro
    Salpietro, Stefania
    Lleo, Ana
    Del Punta, Veronica
    JOURNAL OF HEPATOLOGY, 2020, 73 : S595 - S596